AI Science Tracker
EN

Random forest evaluates two-year risks in a Japanese atrial-fibrillation registry

Fujita Health University · 28 Jul 2021 · medicine

Discovery

Random forest evaluates two-year risks in a Japanese atrial-fibrillation registry

Source check: Source checked. Not independent scientific confirmation.

Finding: Random forest models evaluated two-year thromboembolism, major bleeding and mortality risks in 7,406 patients from the J-RHYTHM atrial-fibrillation registry. Thromboembolism discrimination exceeded logistic regression (C-statistic 0.66 versus 0.59), while mortality discrimination was comparable. This retrospective model evaluation used internal cross-validation; participants were Japanese, most received warfarin, and no direct oral anticoagulants were used. Clinical benefits from using the predictions were not tested.

Technology: Random forest

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
RF with 1,000 trees, training-only feature selection and hyperparameter tuning; 80:20 split and five-fold cross-validation. Prospective registry follow-up does not make this a prospective frozen-model evaluation.
Test and result
Retrospective 7,406-patient risk evaluation against logistic regression and established scores.
Limitation / still unknown
External transportability, clinical benefit and performance under current anticoagulant regimens remain unestablished.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8427975/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary full article Methods, Results and limitations plus Europe PMC bibliographic metadata; PMC full article..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.